Heather J Zar1, Lesley J Workman1, Margaretha Prins1, Linda J Bateman1, Slindile P Mbhele2, Cynthia B Whitman1, Claudia M Denkinger3,4, Mark P Nicol2,5. 1. Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health and. 2. Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa. 3. Foundation for Innovative New Diagnostics, Geneva, Switzerland. 4. Center of Infectious Diseases, University of Heidelberg, Heidelberg, Germany and. 5. School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Abstract
Rationale: Microbiological confirmation of pulmonary tuberculosis in children is desirable. Objectives: To investigate the diagnostic accuracy and incremental yield of Xpert MTB/RIF Ultra (Ultra; Cepheid), a new rapid test, on repeated induced sputum, nasopharyngeal aspirates, and combinations of specimens. Methods: Consecutive South African children hospitalized with suspected pulmonary tuberculosis were enrolled.Measurements and Main Results: Induced sputum (IS) and nasopharyngeal aspirates (NPAs) were obtained. NPAs were frozen; IS underwent liquid culture, and an aliquot was frozen. Ultra was performed on thawed NPAs and IS specimens individually. Children were categorized as confirmed, unconfirmed, or unlikely tuberculosis according to NIH consensus case definitions. The diagnostic accuracy of Ultra was compared with liquid culture on IS. In total, 195 children (median age: 23.3 mo; 32 [16.4%] HIV-infected) had one IS and NPA, and 130 had two NPAs. There were 40 (20.5%) culture-confirmed cases. Ultra was positive on NPAs in 26 (13.3%) and on IS in 31 (15.9%). Sensitivity and specificity of Ultra on one NPA were 46% and 98%, respectively, and similar by HIV status. Sensitivity and specificity of Ultra on one IS were 74.3% and 96.9% respectively. Combining one NPA and one IS increased sensitivity to 80%. Sensitivity using Ultra on two NPAs was 54.2%, increasing to 87.5% with an IS Ultra.Conclusions: IS provides a better specimen than repeated NPA for rapid diagnosis using Ultra. However, Ultra testing of combinations of specimens provides a novel strategy that can be adapted to identify most children with confirmed pulmonary tuberculosis.
Rationale: Microbiological confirmation of pulmonary tuberculosis in children is desirable. Objectives: To investigate the diagnostic accuracy and incremental yield of Xpert MTB/RIF Ultra (Ultra; Cepheid), a new rapid test, on repeated induced sputum, nasopharyngeal aspirates, and combinations of specimens. Methods: Consecutive South African children hospitalized with suspected pulmonary tuberculosis were enrolled.Measurements and Main Results: Induced sputum (IS) and nasopharyngeal aspirates (NPAs) were obtained. NPAs were frozen; IS underwent liquid culture, and an aliquot was frozen. Ultra was performed on thawed NPAs and IS specimens individually. Children were categorized as confirmed, unconfirmed, or unlikely tuberculosis according to NIH consensus case definitions. The diagnostic accuracy of Ultra was compared with liquid culture on IS. In total, 195 children (median age: 23.3 mo; 32 [16.4%] HIV-infected) had one IS and NPA, and 130 had two NPAs. There were 40 (20.5%) culture-confirmed cases. Ultra was positive on NPAs in 26 (13.3%) and on IS in 31 (15.9%). Sensitivity and specificity of Ultra on one NPA were 46% and 98%, respectively, and similar by HIV status. Sensitivity and specificity of Ultra on one IS were 74.3% and 96.9% respectively. Combining one NPA and one IS increased sensitivity to 80%. Sensitivity using Ultra on two NPAs was 54.2%, increasing to 87.5% with an IS Ultra.Conclusions: IS provides a better specimen than repeated NPA for rapid diagnosis using Ultra. However, Ultra testing of combinations of specimens provides a novel strategy that can be adapted to identify most children with confirmed pulmonary tuberculosis.
Authors: Samuel G Schumacher; Maarten van Smeden; Nandini Dendukuri; Lawrence Joseph; Mark P Nicol; Madhukar Pai; Heather J Zar Journal: Am J Epidemiol Date: 2016-10-13 Impact factor: 4.897
Authors: Elisabetta Walters; Marieke M van der Zalm; Anne-Marie Demers; Andrew Whitelaw; Megan Palmer; Corné Bosch; Heather R Draper; H Simon Schaaf; Pierre Goussard; Carl J Lombard; Robert P Gie; Anneke C Hesseling Journal: Pediatr Infect Dis J Date: 2019-06 Impact factor: 2.129
Authors: Anne K Detjen; Andrew R DiNardo; Jacinta Leyden; Karen R Steingart; Dick Menzies; Ian Schiller; Nandini Dendukuri; Anna M Mandalakas Journal: Lancet Respir Med Date: 2015-03-24 Impact factor: 30.700
Authors: S Owens; I E Abdel-Rahman; S Balyejusa; P Musoke; R P D Cooke; C M Parry; J B S Coulter Journal: Arch Dis Child Date: 2006-12-21 Impact factor: 3.791
Authors: Richard A Oberhelman; Giselle Soto-Castellares; Robert H Gilman; Luz Caviedes; Maria E Castillo; Lenka Kolevic; Trinidad Del Pino; Mayuko Saito; Eduardo Salazar-Lindo; Eduardo Negron; Sonia Montenegro; V Alberto Laguna-Torres; David A J Moore; Carlton A Evans Journal: Lancet Infect Dis Date: 2010-07-23 Impact factor: 25.071
Authors: Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi Journal: Cochrane Database Syst Rev Date: 2022-09-06
Authors: B Joshi; H Font; E Wobudeya; M Nanfuka; A Kobusingye; J Mwanga-Amumpaire; N Natukunda; S Turyahabwe; L Borand; T E Mao; B Dim; R Ferhi; R Moh; J Kouakou; R Aka Bony; G Breton; A Mustapha; L Matata; L Foray; A Detjen; S Verkuijl; M Sekadde; C Khosa; V Mbassa; J-V Taguebue; S Kwedi Nolna; M Bonnet; O Marcy; J Orne-Gliemann Journal: Int J Tuberc Lung Dis Date: 2022-03-01 Impact factor: 3.427
Authors: Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas Journal: Cochrane Database Syst Rev Date: 2020-08-27